The United States market remained flat over the last week but has experienced a significant 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking potential gains while aligning with projected growth trends.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| Meridian Holdings (MRDN) |
$7.22 |
$13.90 |
48.1% |
| Golar LNG (GLNG) |
$52.83 |
$102.93 |
48.7% |
| Glaukos (GKOS) |
$122.07 |
$240.69 |
49.3% |
| First Busey (BUSE) |
$26.51 |
$51.46 |
48.5% |
| Coastal Financial (CCB) |
$83.28 |
$161.96 |
48.6% |
| Caris Life Sciences (CAI) |
$19.93 |
$38.57 |
48.3% |
| Capital One Financial (COF) |
$194.11 |
$387.98 |
50% |
| Cadre Holdings (CDRE) |
$29.41 |
$56.96 |
48.4% |
| BioHarvest Sciences (BHST) |
$4.3799 |
$8.60 |
49.1% |
| Alnylam Pharmaceuticals (ALNY) |
$308.51 |
$603.54 |
48.9% |
Let's explore several standout options from the results in the screener.
iRhythm Holdings
Overview:iRhythm Holdings, Inc. is a digital healthcare company focused on developing and commercializing device-based technology for ambulatory cardiac monitoring services to diagnose arrhythmias in the United States, with a market cap of approximately $3.99 billion.
Operations:The company's revenue primarily comes from its Global Ambulatory Cardiac Monitoring Business, which generated $747.14 million.
Estimated Discount To Fair Value:43%
iRhythm Holdings is trading at US$125.96, significantly below its estimated future cash flow value of US$221.15, suggesting it may be undervalued based on cash flows. Despite insider selling in the past quarter, the company anticipates becoming profitable within three years with earnings expected to grow rapidly at 74.91% annually. Recent presentations and collaborations underscore iRhythm's commitment to leveraging AI in cardiology and expanding clinical evidence for its Zio ECG monitoring service.
Ellington Financial
Overview:Ellington Financial Inc., operating through its subsidiary Ellington Financial Operating Partnership LLC, focuses on acquiring and managing a diverse portfolio of mortgage-related, consumer-related, corporate-related, and other financial assets in the United States with a market cap of $1.65 billion.
Operations:Ellington Financial generates revenue from its Longbridge segment ($186.08 million) and Investment Portfolio ($179.81 million).
Estimated Discount To Fair Value:41.9%
Ellington Financial, trading at $13.26, is valued below its estimated future cash flow value of $22.84, indicating potential undervaluation based on cash flows. Despite a 41.9% discount to fair value and expected earnings growth of 22.7% annually—outpacing the US market's 16.2%—the company's dividend sustainability is questionable due to insufficient coverage by earnings or free cash flows and recent shareholder dilution may concern investors.
Hexcel
Overview:Hexcel Corporation develops, manufactures, and markets advanced lightweight composites technology with a market cap of approximately $6.74 billion.
Operations:The company generates revenue from two main segments: Composite Materials, contributing $1.64 billion, and Engineered Products, adding $394.30 million.
Estimated Discount To Fair Value:29.6%
Hexcel, trading at US$92.3, is priced below its estimated future cash flow value of US$131.15, reflecting a potential undervaluation based on cash flows. Earnings are projected to grow significantly at 24.37% annually, surpassing the US market's growth rate of 16.2%. However, Hexcel faces challenges with a high debt level and slower revenue growth compared to the market despite recent positive earnings results and strategic financial maneuvers like fixed-income offerings and credit agreements.
Where To Now?
-
Embark on your investment journey to our 146 Undervalued US Stocks Based On Cash Flows selection here.
-
Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
-
Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Curious About Other Options?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include IRTC EFC and HXL .
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
